CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function.
Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
针对病原体和肿瘤的有效免疫依赖于细胞外脂肪酸对T细胞的成功代谢编程1-3。在此过程中,脂肪酸结合蛋白5(FABP5)导入脂质,为线粒体呼吸提供燃料并维持保护性CD8+ T细胞的生物能量需求4,5。
然而重要的是,调控这一关键免疫代谢轴的机制仍未被探索。在此我们报道,细胞骨架组织蛋白Transgelin 2(TAGLN2)对于CD8+ T细胞的最佳脂肪酸摄取、线粒体呼吸和抗癌功能是必需的。
我们发现TAGLN2与FABP5相互作用,使这一脂质导入蛋白能够定位在活化CD8+ T细胞表面。对卵巢癌标本的分析显示,肿瘤微环境引发的内质网(ER)应激反应抑制了浸润CD8+ T细胞中的TAGLN2,迫使其进入功能障碍状态。在ER应激的CD8+ T细胞中恢复TAGLN2表达可增强其脂质摄取、线粒体呼吸和细胞毒性能力。相应地,过表达TAGLN2的CAR-T 细胞绕过了肿瘤诱导的ER应激的有害影响,并在转移性卵巢癌小鼠中表现出更优的治疗效果。
我们的研究揭示了细胞骨架TAGLN2在T细胞脂质代谢中的作用,并强调了通过保护TAGLN2-FABP5轴来增强实体恶性肿瘤细胞免疫治疗的潜力。
Mounting effective immunity against pathogens and tumors relies on the successful metabolic programming of T cells by extracellular fatty acids 1-3 . During this process, fatty-acid-binding protein 5 (FABP5) imports lipids that fuel mitochondrial respiration and sustain the bioenergetic requirements of protective CD8 + T cells 4,5 .
Importantly, however, the mechanisms governing this crucial immunometabolic axis remain unexplored.
Here we report that the cytoskeletal organizer Transgelin 2 (TAGLN2) is necessary for optimal CD8 + T cell fatty acid uptake, mitochondrial respiration, and anti-cancer function.
We found that TAGLN2 interacts with FABP5, enabling the surface localization of this lipid importer on activated CD8 + T cells. Analysis of ovarian cancer specimens revealed that endoplasmic reticulum (ER) stress responses elicited by the tumor microenvironment repress TAGLN2 in infiltrating CD8 + T cells, enforcing their dysfunctional state.
Restoring TAGLN2 expression in ER-stressed CD8 + T cells bolstered their lipid uptake, mitochondrial respiration, and cytotoxic capacity. Accordingly, chimeric antigen receptor T cells overexpressing TAGLN2 bypassed the detrimental effects of tumor-induced ER stress and demonstrated superior therapeutic efficacy in mice with metastatic ovarian cancer.
Our study unveils the role of cytoskeletal TAGLN2 in T cell lipid metabolism and highlights the potential to enhance cellular immunotherapy in solid malignancies by preserving the TAGLN2-FABP5 axis.
MEMBER ACCOUNT
登录成功会直接打开下一页。